Use of oral anti-diabetic agents in pregnancy: A pragmatic approach

North American Journal of Medical Sciences

Volumn 7, Issue 1, 2015, Pages 6-12

  Kalra, Bharti ^a   Gupta, Yashdeep ^b   Singla, Rajiv ^c   Kalra, Sanjay ^d  

^a Department of Obstetrics and Gynaecology ^*  (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^c Saket City Hospital   (India)

^d India   (India)

Author keywords

Diabetes; Gestational diabetes mellitus; Glibenclamide; Glyburide; Metformin; Treatment

Indexed keywords

ACARBOSE; BIGUANIDE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; SULFONYLUREA; TOLBUTAMIDE;

ARTICLE; BIRTH WEIGHT; BREAST FEEDING; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; LENGTH OF STAY; MACROSOMIA; META ANALYSIS (TOPIC); NEWBORN JAUNDICE; NONHUMAN; PATIENT SATISFACTION; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TERATOGENICITY; WEIGHT GAIN;

EID: 84921914396     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.150081     Document Type: Article

References (37)

1. Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:176-85.
2. Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227-49.
3. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, et al. Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
4. Guideline Development Group. Management of diabetes from preconception to the postnatal period: Summary of NICE guidance. BMJ 2008;336:714-7.
5. Berggren EK, Boggess KA. Oral agents for the management of gestational diabetes. Clin Obstet Gynecol 2013;56:827-36.
6. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): Body composition at 2 years of age. Diabetes Care 2011;34:2279-84.
7. Tieu J, Coat S, Hague W, Middleton P. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/ impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database Syst Rev 2010;10:CD007724.
8. Refuerzo JS. Oral hypoglycemic agents in pregnancy. Obstet Gynecol Clin North Am 2011;38:227-34.
9. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: A meta-analysis. PLoS One 2013;8:e64585.
10. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-15.
11. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83:1575-8.
12. Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 2006;28:67-72.
13. Briggs GG, Ambrose PJ, Nageotte MP, Padilla G, Wan S. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005;105:1437-41.
14. Gardiner SJ, Kirkpatrick CM, Begg EJ, Zhang M, Moore MP, Saville DJ. Transfer of metformin into human milk. Clin Pharmacol Ther 2003;73:71-7.
15. Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF. Transfer of metformin into human milk. Diabetologia 2002;45:1509-14.
16. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19:1323-30.
17. Feig DS, Moses RG. Metformin therapy during pregnancy: Good for the goose and good for the gosling too? Diabetes Care 2011;34:2329-30.
18. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship of fetal hyperinsulinism. Diabetes Care 1995;18:611-7.
19. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: A systematic review. Obstet Gynecol 2009;113:193-205.
20. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13:427-8.
21. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 2013;39:1147-52.
22. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
23. Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007;76:474-5.
24. Bertini AM, Silva JC, Taborda W, Becker F, Lemos Bebber FR, Zucco Viesi JM, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33:519-23.
25. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: A systematic review and metaanalysis. Am J Obstet Gynecol 2010;203:457.e1-9.
26. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer. Am J Obstet Gynecol 1994;171:653-60.
27. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165:807-12.
28. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995;18:1446-51.
29. Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G. The safety of oral hypoglycemic agents in the first trimester of pregnancy: A meta-analysis. Can J Clin Pharmacol 2003;10:179-83.
30. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metabol 2007;51:541-6.
31. Feig DS, Briggs GG, Kraemer JM, Ambrose PJ, Moskovitz DN, Nageotte M, et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005;28:1851-5.
32. Glatstein MM, Djokanovic N, Garcia-Bournissen F, Finkelstein Y, Koren G. Use of hypoglycemic drugs during lactation. Can Fam Physician 2009;55:371-3.
33. Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 2012;40:225-8.
34. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet 2010;111:37-40.
35. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: A randomized controlled trial. Obstet Gynecol 2010;115: 55-9.
36. Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med 2014;31:282-91.
37. Kalra B, Gupta Y. Pragmatic use of metformin in pregnancy based on biopsychosocial model of health. Indian J Endocrinol Metab 2013;17:1133-5.